After an internship and residency in Internal Medicine at Barnes Hospital, Washington University in St. Louis (1982-84), Dr Gimble completed a Medical Staff Fellowship in the Laboratory of Immunogenetics, NIAID, NIH (1984-87). Dr. Gimble began studying the differentiation properties of bone marrow stromal cells, now known as mesenchymal stem cells (MSCs), in 1987 as a faculty member at the Oklahoma Medical Research Foundation. His laboratory was among the first to investigate the molecular biology of bone marrow stromal adipogenesis.
In 1999, Dr. Gimble left academia to join Zen-Bio as its Director of Tissue Engineering. In 2000, Dr Gimble co-founded Artecel Sciences, where he served as Chief Scientific Officer and whose mission was to develop tissue engineering products based on the use of human adipose-derived stem cells. After the sale of the company in 2003, Dr. Gimble joined the Pennington Biomedical Research Center where he remained on faculty until 2013 as a tenured Professor developing methods for the isolation and characterization of adipose derived stem cells for regenerative medicine. In 2010, he co-founded LaCell, a biotech company delivering premium quality human stem cell products to research laboratories.
Dr. Gimble currently serves as LaCell’s Chief Scientific Officer whilst continuing to serve as an Adjunct Professor in the Center for Stem Cell Research and Regenerative Medicine at Tulane University School of Medicine.